Purchases and Sales Made in Q2 2024 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q2 2024. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-279K- 44.34% |
$11.8M - $14.5M
|
351K
$14.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-324K- 23.33% |
$13.7M - $16.8M
|
1.07M
$43.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-325K- 30.63% |
$13.7M - $16.8M
|
735K
$29.8M
|
|
|
Aug 14, 2024
Q2 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-431K- 68.2% |
$18.2M - $22.4M
|
201K
$8.16M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-442K- 13.59% |
$18.6M - $23M
|
2.81M
$114M
|
|
|
Aug 14, 2024
Q2 2024
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-490K- 28.97% |
$20.6M - $25.4M
|
1.2M
$48.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-611K- 19.57% |
$25.8M - $31.7M
|
2.51M
$102M
|
|
|
Aug 14, 2024
Q2 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.31M- 49.25% |
$55.1M - $67.9M
|
1.35M
$54.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-2.17M- 43.82% |
$91.3M - $113M
|
2.78M
$113M
|